Technology Times New Jersey: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Times New Jersey.

Press releases published on June 30, 2026

Jun. 30, 2026

Innventure Announces Appointment of Dr. Bill Grieco as CEO following Retirement of Current CEO Bill Haskell

Indeterminate GlobeNewswire

Jun. 30, 2026

Welcome to Robot Park: Where Apptronik’s Apollo Goes to Work Training the Next Generation of Humanoid Robot Intelligence

Indeterminate GlobeNewswire

Jun. 30, 2026

Two Six Technologies Deploys SIGMA to Support FIFA World Cup 2026TM Security Operations

Indeterminate GlobeNewswire

Jun. 30, 2026

VisionWave Signs Definitive Agreement to Acquire Controlling Interest in Meteor Aerospace

Indeterminate GlobeNewswire

Jun. 30, 2026

Design Therapeutics Announces Initiation of Patient Dosing in Phase 1 Multiple Ascending Dose Trial of DT-818 for Myotonic Dystrophy Type-1

Indeterminate GlobeNewswire

Jun. 30, 2026

Genius Group Investors file Class Action Lawsuit against Citadel Securities and Virtu Americas for Alleged Market Manipulation.

Indeterminate GlobeNewswire

Jun. 30, 2026

Kneat Files Management Information Circular in Connection with the Previously Announced Thoma Bravo Transaction

Indeterminate GlobeNewswire

Jun. 30, 2026

TrustEvals, Founded by Unmukt Raizada, Launches Next-Generation AI Governance for Financial Services, Real Estate firms, and Enterprise Audits

Indeterminate GlobeNewswire

Jun. 30, 2026

ZenaTech Reports Annualized Revenue Run Rate of Approximately CAD $33 Million Based on First Quarter 2026 Revenue

Indeterminate GlobeNewswire

Jun. 30, 2026

Pacira BioSciences Announces Agreement to Divest its iovera° Business to Zimmer Biomet

Indeterminate GlobeNewswire

Jun. 30, 2026

OptimizeRx Launches CopayCue™, a Next-Generation Copay Activation Solution Powered by Real-Time Prescribing Intent

Indeterminate GlobeNewswire

Jun. 30, 2026

Plus Therapeutics Provides Mid-Year Business Update Including Corporate Rebranding

Indeterminate GlobeNewswire

Jun. 30, 2026

InflaRx Assessing Feasibility of Broadened Strategy for ANCA‑Associated Vasculitis in Europe Following EMA Recommendation on Tavneos

Indeterminate GlobeNewswire

Jun. 30, 2026

Pyxis Oncology Announces Up to $114 Million Private Placement Financing to Advance MICVO Through Key Clinical Milestones

Indeterminate GlobeNewswire

Jun. 30, 2026

Blockfusion and Blue Acquisition Corp. Announce LOIs for Anchor Lease with a Leading AI Customer and $175 Million Convertible Note Financing and Non-Redemption Agreement, and Advancement of Planned Expansion of Niagara Falls Campus

Indeterminate GlobeNewswire

Jun. 30, 2026

Bilibili Inc. Provides Update on Share Repurchase Program

Indeterminate GlobeNewswire

Jun. 30, 2026

AC Immune Reports Interim 12-Month Data from Phase 1b/2 ABATE Trial of ACI-24 in Prodromal Alzheimer’s Disease

Indeterminate GlobeNewswire

Jun. 30, 2026

R1 Therapeutics establishes world-class Scientific Advisory Board to support advancement of AP306 in Chronic Kidney Disease

Indeterminate GlobeNewswire

Jun. 30, 2026

Nomerra raises $2 million to tackle private markets’ looming paperwork crisis

Indeterminate GlobeNewswire

Jun. 30, 2026

Charles IT Named to 2026 MSP 501 — Tech Industry's Most Prestigious Ranking of Global Managed Service Providers

Indeterminate GlobeNewswire